Global Community

1. Platform Model: Mobility, Delivery & Logistics Uber operates a global two-sided marketplace , connecting riders, couriers, and freight shippers with independent drivers without owning vehicles or inventory.

Pipeline Crenessity@ CRENESSITY Capsule 50/100 MG $766.66 packaging 50 MG 60u $45,999.60 packaging 100 MG 30u. Starts at approximately $21,338.71 USD for a monthly supply Ingrezza@ Ingrezza (valbenazine) As of July 2025 , the average pharmacy acquisition cost for Ingrezza capsules in the U.S. is approximately: $274.54 per capsule for the 60 mg and 80 mg strengths $250.16 per capsule for the 40 mg strength Other Products: Tetrabenazine Tablet 12.5 MG $62.52 Austedo Tablet 6 MG $100.06 Austedo XR Tablet 6 MG $100.06 Xenazine Tablet 12.5 MG $227.88 Assumptions Risks Risks and uncertainties associated with Neurocrine Biosciences' business and finances in general, risks and uncertainties associated with the commercialization of INGREZZA and CRENESSITY.

Shorts are manipulating the stock. The fundamentals are too strong to ignore.

Today, July 29 Novo revised its full year 2025 guidance downward: Sales growht in local currencies now expected 8% - 14%. (down from 13% -21%.) Operating profit growth: now expected 10% -16%, ( down from 16% x24%).

competitor to adobe. (media production software--very active sector) new issue (IPO) subscription buyers at $32.

Catalysts Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directly fueling sales of Pattern Generators, dispensing/coating and photonics tools. Proven pricing power — gross margin has averaged 54 % over the past decade (≈ 40 % lowpint), showing customers pay a premium for Mycronic’s precision and uptime.

1. Continuous Product and Service Expansion DLocal emphasizes continuous investment in developing new products and services.

Americas Gold and Silver Corporation (TSXV: USA) – 5-Year Outlook (2025–2029) This analysis evaluates the potential performance of Americas Gold and Silver Corporation (TSXV: USA) over the next five years, based on the assumptions: successful production at Cosalá Operations (including the EC120 project) and the Galena Complex, a silver price of $100/oz, gold price of $4,000/oz, oil price of $60/barrel, 7.5% annual inflation, a gold and silver bull market from 2025–2029 and no stock dilution. All financial figures are in USD unless otherwise stated.

This stock was affected by the Tritium Collapse (losing sales momentum for two years), but remains a significant and efficient supplier of EV Rectifiers. It has a large European customer as well as Australian Defence and Telecommunications.